News

Understand how psoriatic arthritis increases heart disease risk through inflammation. Learn management tips for heart health, from lifestyle changes to medication discussions.
Hidradenitis suppurativa is associated with a higher risk for new-onset depression and anxiety, which may occur despite ...
High uric acid is a health concern. It links to gout, kidney issues, and heart problems. Obesity and diabetes worsen it. The ...
Alfasigma announces positive results from OLINGUITO phase 3 trial of filgotinib to treat adult patients with active axial spondyloarthritis: Bologna Wednesday, July 30, 2025, 18:0 ...
A class of existing autoimmune drugs may offer a novel strategy to prevent or reverse a rare but serious complication of ...
A new study from scientists at Scripps Research suggests that a drug already approved by the FDA to treat inflammation could help people with alcohol use disorder (AUD) by reducing both alcohol ...
Patients with type 2 diabetes, treated with GLP-1 receptor agonists, show a decreased risk of being diagnosed with ...
Tildrakizumab is an interleukin-23 antagonist approved under the brand name Ilumya for the treatment of plaque psoriasis.
As July draws to a close, it's time to take a look at what's in store in the health and wellness space over the upcoming weeks.August, the last month of summer, includes several ...
Regardless of dose used, povorcitinib use for 24 weeks among patients with extensive nonsegmental vitiligo improved total and facial repigmentation.